Scholarlink

Background <p>A&#xa0;high quality of biosample-associated data (DQ) is critical for biomedical research. Synoptic reporting (SR) provides the chance to increase DQ for the secondary use of data from surgical pathology (SP) in Germany. Hence, it is of high interest for biobanks that data-providing SP departments force the implementation of SR.</p> Materials and methods <p>Synoptic reporting is already implemented in some use cases [<CitationRef CitationID="CR1">1</CitationRef>]. Recommendations for how to proceed are available [<CitationRef AdditionalCitationIDS="CR3" CitationID="CR2">2</CitationRef>–<CitationRef CitationID="CR4">4</CitationRef>]. Central efforts—such as the DGP’s <i>AG Semantik</i>—are carried out to support standardisation in SR.</p> Results <p>Successful use of SR requires efforts from SP departments as well as from biobanks. Firstly, it requires revision of processes in SP departments. This also applies to the similar tissue assessment processes in biobanks. Secondly, biobanks need to prepare by implementing the required standards such as FHIR and SNOMED CT.</p> Conclusion <p>Common efforts in SP departments and biobanks are required to facilitate the utmost benefits of SR for DQ in patient care and research. Biobanks can serve as a&#xa0;platform for SP departments to attempt new processes that implement SR and can provide independent feedback on DQ in SP departments.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Synoptic reporting

  • 期刊论文

  • 发表日期：

    2025年12月8日

查看全文
  • Julian Dörenberg

摘要

Background

A high quality of biosample-associated data (DQ) is critical for biomedical research. Synoptic reporting (SR) provides the chance to increase DQ for the secondary use of data from surgical pathology (SP) in Germany. Hence, it is of high interest for biobanks that data-providing SP departments force the implementation of SR.

Materials and methods

Synoptic reporting is already implemented in some use cases [1]. Recommendations for how to proceed are available [2–4]. Central efforts—such as the DGP’s AG Semantik—are carried out to support standardisation in SR.

Results

Successful use of SR requires efforts from SP departments as well as from biobanks. Firstly, it requires revision of processes in SP departments. This also applies to the similar tissue assessment processes in biobanks. Secondly, biobanks need to prepare by implementing the required standards such as FHIR and SNOMED CT.

Conclusion

Common efforts in SP departments and biobanks are required to facilitate the utmost benefits of SR for DQ in patient care and research. Biobanks can serve as a platform for SP departments to attempt new processes that implement SR and can provide independent feedback on DQ in SP departments.